MEOI and HRQoL in CLL patients treated with BTKis

Trial Identifier: D8220R00036
Sponsor: AstraZeneca
NCTID:: NCT04938141
Start Date: October 2021
Primary Completion Date: September 2024
Study Completion Date: September 2024
Condition: CLL (Chronic Lymphocytic Leukemia)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
US, California Fountain Valley, California, US, 92708
US, California Redlands, California, US, 92373
US, Florida Boca raton, Florida, US, 33486
US, Florida Fort Lauderdale, Florida, US, 33308
US, Florida Petersburg, Florida, US, 33709
US, Florida Tallahassee, Florida, US, 32308
US, Florida Tamarac, Florida, US, 33321
US, Florida Tampa, Florida, US, 33705-1407
US, Georgia Savannah, Georgia, US, 31405
US, Hawaii Honolulu, Hawaii, US, 96813-5516
US, Mississippi Jackson, Mississippi, US, 39202
US, New Jersey Berkley Heights, New Jersey, US, 07922
US, New York Amherst, New York, US, 14228
US, North Carolina Charlotte, North Carolina, US, 27103
US, Pennsylvania Philadelphia, Pennsylvania, US, 19111
US, Pennsylvania York, Pennsylvania, US, 17403